Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles in IPO/Stock Watch

Lepu Completes $116 Million HK IPO; Trades Flat in Opening Sessions
Lepu Bio Seeks to Raise $115 Million in Hong Kong IPO
Mabwell Stages $547 Million IPO on STAR Board for Antibody Portfolio
Sirnaomics Raises $64 Million in Hong Kong IPO for RNA Therapies
BeiGene Begins Trading on Shanghai STAR Board; Slides 17% Lower
ChinaBio Event
Beijing and Digital
September 13-16, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022